About Isabl
Isabl is a company based in New York (United States) founded in 2020 by Juan Medina, Andrew Kung, and Elli Papaemmanuil.. Isabl has raised $3 million across 2 funding rounds from investors including HHS, Box 1 and Evolution VC Partners. The company has 3 employees as of December 31, 2024. Isabl offers products and services including Isabl GxT and WGTS SaaS. Isabl operates in a competitive market with competitors including Denali Therapeutics, Strand Life Sciences, Poseida Therapeutics, Castle Biosciences and Juno Therapeutics, among others.
- Headquarter New York, United States
- Employees 3 as on 31 Dec, 2024
- Founders Juan Medina, Andrew Kung, Elli Papaemmanuil
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Isabl Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$3 M (USD)
in 2 rounds
-
Latest Funding Round
$2.03 M (USD), Grant
Apr 01, 2023
-
Investors
HHS
& 6 more
-
Employee Count
3
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Isabl
Isabl offers a comprehensive portfolio of products and services, including Isabl GxT and WGTS SaaS. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Analyzes entire tumor genome and transcriptome for cancer mutation detection
Platform for whole genome tumor sequencing services in cancer care
Unlock access to complete
Unlock access to complete
Funding Insights of Isabl
Isabl has successfully raised a total of $3M across 2 strategic funding rounds. The most recent funding activity was a Grant round of $2.03 million completed in April 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Grant — $2.0M
-
First Round
First Round
(01 Jun 2022)
- Investors Count 7
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2023 | Amount | Grant - Isabl | Valuation |
investors |
|
| Jun, 2022 | Amount | Seed - Isabl | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Isabl
Isabl has secured backing from 7 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include HHS, Box 1 and Evolution VC Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments in tech startups are made by Evolution VC Partners.
|
Founded Year | Domain | Location | |
|
Angel funding is provided to Silicon Valley-based companies.
|
Founded Year | Domain | Location | |
|
Early-stage investments in tech sectors are managed by the firm.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Isabl
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Isabl
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Isabl Comparisons
Competitors of Isabl
Isabl operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Denali Therapeutics, Strand Life Sciences, Poseida Therapeutics, Castle Biosciences and Juno Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Neurodegenerative disease therapies are developed for Alzheimer's, ALS, and Parkinson's.
|
|
| domain | founded_year | HQ Location |
Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery
|
|
| domain | founded_year | HQ Location |
Developer of gene therapies for treating cancer and liver orphan disease by using gene editing technologies
|
|
| domain | founded_year | HQ Location |
Precision diagnostic and prognostic tests are developed by Castle Biosciences.
|
|
| domain | founded_year | HQ Location |
CAR T-cell and T-cell receptor immunotherapies for cancer are developed.
|
|
| domain | founded_year | HQ Location |
Genomic sequencing and diagnosis software is provided for healthcare.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Isabl
When was Isabl founded?
Isabl was founded in 2020 and raised its 1st funding round 2 years after it was founded.
Where is Isabl located?
Isabl is headquartered in New York, United States. It is registered at New York, New York, United States.
Who is the current CEO of Isabl?
Elli Papaemmanuil is the current CEO of Isabl. They have also founded this company.
Is Isabl a funded company?
Isabl is a funded company, having raised a total of $3M across 2 funding rounds to date. The company's 1st funding round was a Seed of $3M, raised on Jun 01, 2022.
How many employees does Isabl have?
As of Dec 31, 2024, the latest employee count at Isabl is 3.
What does Isabl do?
Isabl was founded in 2020 in New York, United States, within the healthcare technology sector. A platform for medical diagnosis is developed to examine genomes of cancer patients. The Isabl GxT platform is utilized to assess both genome and transcriptome data, enabling identification of mutations, disease monitoring, and biomarker detection. Operations focus on genomic analysis services for oncology applications.
Who are the top competitors of Isabl?
Isabl's top competitors include Strand Life Sciences, Juno Therapeutics and Personalis.
What products or services does Isabl offer?
Isabl offers Isabl GxT and WGTS SaaS.
Who are Isabl's investors?
Isabl has 7 investors. Key investors include HHS, Box 1, Evolution VC Partners, Milad Alucozai, and Sand Hill Angels.